Accès ouvert
2025
dissertation
OpenAlex
Nina Barner‐Rasmussen
Background: Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and fibrosis of the bile ducts, often leading to liver cirrhosis and, eventually, liver failure. There is an increased risk of malignancy, especially hepatobiliary malignancy. Despite significant morbidity, …
Accès ouvert
2025
article
OpenAlex
Nina Barner‐Rasmussen, Antonio Molinaro, Bregje Mol, Cyriel I. J. Ponsioen et autres
Background: Primary sclerosing cholangitis (PSC) is associated with a high risk of hepatobiliary malignancy, especially cholangiocarcinoma (CCA). There are no good tumor markers to screen for CCA, and current recommendations for PSC monitoring are mainly based on expert opinions. The optimal strategy …
fi, se, nl
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Eve Ronkainen, Nina Barner‐Rasmussen, Kirsi Volmonen, Martti A. Färkkilä et autres
BACKGROUND AND AIM: Esophageal duplication cysts (EDCs) are rare congenital malformations, often discovered incidentally during endoscopy or on computed tomography (CT) scans. The role of endoscopic ultrasound (EUS) and CT scan in the diagnosis of these lesions and indications for surgical treatment …
fi
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Mathias Thylin, Martti A. Färkkilä, Hannu Kautiainen, Nina Barner‐Rasmussen et autres
BACKGROUND AND AIMS: A new definition of dominant stricture (NDS) has recently been defined for patients with primary sclerosing cholangitis (PSC). Prevalence and clinical features of this, compared to traditional dominant stricture (TDS), have not been reported. METHODS: In this single-centre longitudinal …
fi
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Nina Barner‐Rasmussen, Nelli Sjöblom, Johanna T. Arola, Sonja Boyd et autres
OBJECIVES: At present, no sensitive or specific screening test exists for primary sclerosing cholangitis (PSC). PSC screening is mainly based on elevated alkaline phosphatase (ALP) in patients with inflammatory bowel disease (IBD). We aimed to produce a screening score based on laboratory …
fi
(code pays fourni par la source)
2023
article
OpenAlex
Andrea Tenca, Hannu Kautiainen, Mathias Thylin, Lauri Puustinen et autres
Accès ouvert
2023
article
OpenAlex
Touko T. Kaasalainen, A. Pekkarinen, Leena Kylänpää, Mia Rainio et autres
Abstract Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) procedures may result in remarkable radiation doses to patients and staff. The aim of this prospective study was to determine occupational exposures in gastrointestinal endoscopy procedures, with a special emphasis on eye lens …
fi
(code pays fourni par la source)
2022
article
OpenAlex
Nina Barner‐Rasmussen, Nelli Sjöblom, Hannu Kautiainen, Johanna T. Arola et autres
Accès ouvert
2021
article
OpenAlex
Nina Barner‐Rasmussen, Eero Pukkala, Kishor Hadkhale, Martti A. Färkkilä
BACKGROUND: Cholangiocarcinoma (CCA) is a cancer arising from the intra- and extrahepatic bile ducts. The early stages are often asymptomatic, CCA is frequently diagnosed in an advanced stage and the prognosis of CCA is often dismal. OBJECTIVE: Our objective was to estimate …
fi
(code pays fourni par la source)
2020
article
OpenAlex
Nina Barner‐Rasmussen, Eero Pukkala, Airi Jussila, Martti A. Färkkilä
Background: There are only a few and mostly small population-based epidemiological studies of primary sclerosing cholangitis (PSC).Objective: We aimed to estimate prevalence and incidence rates of PSC, and survival and malignancy risk for PSC patients in a large population-based study.Methods: We retrieved …
fi
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Lauri Puustinen, Nina Barner‐Rasmussen, Eero Pukkala, Martti A. Färkkilä
fi
(code pays fourni par la source)
2017
article
OpenAlex
Nina Barner‐Rasmussen, Martti A. Färkkilä